unnamed.jpg

Orum Therapeutics

Licenses TPD-based blood cancer therapy to BMS

View Site
  • Fund Smart Crystal Untact Fund 1
  • Investment Year Jan 2023
  • Status Liquidated
  • Country Boston, USA/Daejeon, Korea